AKT1 and prostate carcinoma: Mi Kyung Park et al. [92] also found that USP11 is downregulated in prostate cancer, related to PTEN instability and poorer prognosis, the USP11-PTEN-PI3K-AKT loop signaling pathway regulates the occurrence and progression of prostate cancer.